{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-072683","form_type":"8-K","ticker":"ORKA","cik":"0000907654","company_name":"Oruka Therapeutics, Inc.","filed_at":"2024-08-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.257312+00:00","generated_at":"2026-05-31T07:32:23.046410+00:00","sec_items":["8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"ARCA sets special dividend at $1.613/share for Oruka merger; ex-date Aug 29","bullets":["Special cash dividend of $1.613 per share payable on Aug 28 to holders of record Aug 26.","Ex-dividend date set for Aug 29 due to dividend exceeding 25% of stock price; due bill period Aug 25-28.","Merger with Oruka Therapeutics expected to close Aug 29; combined company to trade as ORKA on Nasdaq Global Market.","Reverse stock split at 1-for-12 effective Sept 3, 2024, after merger close."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-072683","json":"https://secwatch.observer/filing/0001213900-24-072683.json","markdown":"https://secwatch.observer/filing/0001213900-24-072683.md","text":"https://secwatch.observer/filing/0001213900-24-072683.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/907654/000121390024072683/0001213900-24-072683-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/907654/000121390024072683/ea0212462-8k425_arcabio.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T07:32:23.046410+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}